Anthony Barron is speaking during the symposium on the topic of “Presentation on the Value of Personalized Medicines.”
For more information on this event, click here.
Implications of the Inflation Reduction Act for cancer medicine development
The Inflation Reduction Act (IRA) Medicare Drug Price Negotiation Program (MDPNP) directs the Secretary of Health and Human Services (HHS) to set a maximum...